Northwest Biotherapeutics's total assets for Q1 2025 were $27.50M, an increase of 2.91% from the previous quarter. NWBO total liabilities were $112.34M for the fiscal quarter, a -7.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.